160 filings
Page 4 of 8
6-K
njohq79krug8ib8c
15 Dec 22
Current report (foreign)
8:00am
6-K
r338c vzns5vazppdqy1
8 Dec 22
Immunoprecise Antibodies LTD. 6-K
8:05am
6-K
3cmkwqn
5 Dec 22
The Company to host an earnings conference call via webcast
8:51am
6-K
ub9698vq0ko3s4
30 Nov 22
Immunoprecise Antibodies LTD. 6-K
8:08am
6-K
g8tbrwo1
22 Nov 22
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
p1nwp
17 Nov 22
Current report (foreign)
9:36am
6-K
kie8mckuit
1 Nov 22
Current report (foreign)
7:07pm
6-K
qe9mr
17 Oct 22
Annual General and Special Meeting
7:07am
6-K
k7ackzcg
12 Oct 22
Immunoprecise Antibodies LTD. 6-K
8:09am
6-K
g2lx xq5io
14 Sep 22
Immunoprecise Antibodies LTD. 6-K
8:31am
6-K
9haf6d 7dzq
14 Sep 22
Current report (foreign)
8:31am
6-K
ws2orlu47df ah
14 Sep 22
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
nsacno7omut7mc
8 Sep 22
The Company to host an earnings conference call via webcast
9:14am
6-K
fsju3n
29 Aug 22
Immunoprecise Antibodies LTD. 6-K
8:08am
40-F
ba28mpqbv3
29 Jul 22
Annual report (Canada)
9:04am
6-K
5ozd2n
29 Jul 22
Immunoprecise Antibodies LTD. 6-K
8:17am
6-K
2hz5n7b jxde4q2
26 Jul 22
The Company to host an earnings conference call via webcast
8:12am
6-K
vrchuern8ksjnv mdo7
12 Jul 22
Immunoprecise Antibodies LTD. 6-K
8:16am
6-K
lgeh20
9 May 22
IPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTsâ„¢ with 3D protein structure and function
8:15am
6-K
xtt3gbkyd6d8
25 Apr 22
Form 51-102F3 MATERIAL CHANGE REPORT
1:13pm